Answers are grounded in this paper and cite their sources.
Objective: In this study, we aim to present the retrospective results of percutaneous biopsies performed on solid kidney lesions in our clinic with the literature. Materials and Methods: In this retrospective descriptive study approved by the ethics committee in our center, the demographic features and histopathological results of 57 patients who had a solid mass in the kidney between 2017-2020 and underwent ultrasonography-guided percutaneous kidney biopsy in our interventional radiology clinic were analyzed from the hospital database. Patients without pathology results were excluded from the study. Results: Our patients consisted of 35 men (61,4%) and 23 women (38,6%). The average age was 59.02±15.33(6-94). We had 1 child and 56 adult patients. 29 of the kidney lesions were located in the left kidney(50,9%) and 28 were located in the right kidney(49,1%). In 44 patients(77.2%) who had malignant pathology; the results were 41 renal cell carcinoma(93.2%), 2 lung squamous cell carcinoma metastasis(4.5%) and 1 primary metastatic pleomorphic adenoma of the salivary gland(2.3%). In a total of 13 patients(22.8%) whose pathology results were benign; the results were 5 oncocytomas(38.5%), 5 angiomyolipoma(38.5%), 2 chronic pyelonephritis(15.4%) and 1 metanephric adenoma(7.6%). Renal cell carcinoma rate was 71.9% among all lesions. Conclusion: Radiological methods may not provide sufficient diagnostic data in the differential diagnosis of solid renal masses.In our study, the rates of benign lesions as a result of percutaneous biopsy were higher compared to the literature. Therefore, we believe that it is remarkable in terms of the importance of preoperative biopsy in solid lesions.
No takes yet. Share an insight, caveat, or question.
Dündar et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: